Should you buy GoodRx holdings (GDRX) in 2024?

Fintel reports that on May 23, 2024, RBC Capital upgraded their outlook for GoodRx Holdings ( NasdaqGS:GDRX) from Sector Perform to Outperform. Analyst Price Forecast Suggests 30.06% Upside As of May 22, 2024, the average one-year price target for GoodRx Holdings is 9.36. The forecasts range from a low of 5.05 to a high of $16.80.

Who is GoodRx holdings?

GoodRx Holdings Background Information (This description is provided by the company.) GoodRx Holdings, Inc. is a holding company that provides price comparison tool for prescriptions. The Company provides GoodRx platform, which aggregates and analyzes pricing data from a number of different sources.

Does Ameriprise Financial own GDRX?

its portfolio allocation in GDRX by 12.03% over the last quarter. Ameriprise Financial holds 7,438K shares representing 1.98% ownership of the company. In its prior filing, the firm reported owning 7,002K shares , representing